How Many Products Are In Development For Neglected Tropical Diseases? BVGH Takes A Closer Look
This article was originally published in PharmAsia News
Executive Summary
In a recent report, the nonprofit BIO Ventures for Global Health shines a light on the NTD pipelines of Big Pharma, biotechs and others.
You may also be interested in...
TB Regimen Could Pave Way For More FDA Involvement In Neglected Tropical Diseases
TB Alliance plans to seek FDA approval for its treatment regimen, which is beginning a Phase IIb trial, as the agency looks to respond to calls for a clearer and quicker pathway for NTD drugs.
Southeast Asian Regulators Ramp Up Anti-Corruption, Bribery Enforcement Ahead of ASEAN Pact
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.
St. Jude Introduces Allure Quadra To Hong Kong As It Seeks APAC Rebound For Pacemakers
The first commercial implant for St. Jude’s Allure Quadra in Hong Kong is a sign for optimism for its pacemaker business after last year’s disappointments in Japan.